NCT04395144View on ClinicalTrials.gov

COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 15, 2020

Primary Completion Date

March 15, 2021

Study Completion Date

March 15, 2021

Conditions
Coronavirus InfectionCOVIDSevere Acute Respiratory SyndromeRespiratory FailureRespiratory InsufficiencyRespiratory Distress SyndromeARDSLung Diseases
Interventions
PROCEDURE

Awake Prone Positioning

Patients will receive instruction to remain in prone position as long and as often as possible, up to 16h/24h

PROCEDURE

Standard care

Patients will not receive any special instructions with regards to proning.

Trial Locations (5)

G4X 2W2

Hôtel-Dieu de Gaspé, Gaspé

H7M 3L9

Hôpital de la Cité-de-la-Santé, Laval

H3G 1A4

Montreal General Hospital, McGill University Healthcare Center, Montreal

H4A 3J1

Royal Victoria Hospital, McGill University Healthcare Center, Montreal

H4G2A2

Hôpital de Verdun, Montreal

All Listed Sponsors
lead

Hôpital de Verdun

OTHER

NCT04395144 - COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss | Biotech Hunter | Biotech Hunter